Ipsen Pharma

Ipsen is a pharmaceutical company that develops and commercializes generic medicines for the treatment of oncology and neuroscience diseases. Read more

David Loew's photo - CEO of Ipsen Pharma

CEO

David Loew

CEO Approval Rating

86/100

Founded:

1929

Status:

PublicIndependent CompanyPAIPN

IPSEN PHARMA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Mylan has been one of Ipsen Pharma's top competitors. Mylan is a Private company that was founded in 1961 in Canonsburg, Pennsylvania. Like Ipsen Pharma, Mylan also competes in the Pharmaceuticals sector. Compared to Ipsen Pharma, Mylan has 29,200 more employees.

TEVA is seen as one of Ipsen Pharma's biggest rivals. TEVA is a Public company that was founded in Petach Tikva, Center District in 1901. Like Ipsen Pharma, TEVA also operates in the Pharmaceuticals sector. TEVA has 34,416 more employees vs. Ipsen Pharma.

Regeneron is perceived as one of Ipsen Pharma's biggest rivals. Regeneron was founded in Tarrytown, New York} in 1988. Like Ipsen Pharma, Regeneron also competes in the Pharmaceuticals space. Compared to Ipsen Pharma, Regeneron generates $6.3B more revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Akorn a competitor of Ipsen Pharma?

Ipsen Pharma Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$2.9B

Ipsen Pharma's revenue is the ranked 14th among it's top 10 competitors. The top 10 competitors average 25.4B. Over the last two quarters, Ipsen Pharma's revenue has decreased by 1.6%. Specifically, in Q3 2020's revenue was $678.9M; in Q2 2020, it was $690.1M.

Ipsen Pharma Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Clementia Pharmaceuticals, Inc.

Feb 2019

Source »
$1.3B
Clementia develops drug candidates for the treatment of bone disorders.

-

Global Oncology Business, Merrimack Pharmaceuticals

Apr 2017

Source »
$575M
-
onivyde

Jan 2017

Source »
$575M
ONIVYDE is engaged in the development and commercialization of drugs for the treatment of patients with metastatic pancreatic cancer.
OctreoPharm Sciences GmbH

May 2015

Source »
undisclosed
OctreoPharm Sciences is a clinical development firm focusing on radiopharmaceuticals for the diagnosis and therapeutic control of tumors.

-

Tercica

Oct 2008

Source »
undisclosed
-

These are all the companies that Ipsen Pharma has acquired. Ipsen Pharma has acquired 5 companies and its latest acquisition was Clementia Pharmaceuticals, Inc. in Feb 2019. Clementia develops drug candidates for the treatment of bone disorders.

Ipsen Pharma Funding History

No recent funding data found related to Ipsen Pharma

Ipsen Pharma Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Pyxis Oncology is a Massachusetts-based biotechnology company that develops and commercializes antibody therapeutics for the treatment of cancer.
$22M
Jul 16, 2019
Series A
-
Rhythm is a biopharmaceutical company that develops and commercializes peptide therapeutics for the treatment of genetic disorders.
$40M
Aug 02, 2015
Series A
Oct 05, 2017
Dicerna is a developer of investigational ribonucleic acid interference therapeutics for liver, cardiovascular and viral infectious diseases.
$25M
Aug 10, 2010
Series B
Jan 29, 2014

These are all the companies that Ipsen Pharma has invested in. Ipsen Pharma has invested 5 companies and its latest investment was Clementia Pharmaceuticals, Inc. in Feb 2019. Clementia develops drug candidates for the treatment of bone disorders.

Ipsen Pharma News

June 2, 2021MarketScreener

Initiates a Share Buy-back Program to Cover Its Performance and Employee Share Plans

(marketscreener.com) Regulatory News: Ipsen has appointed an investment-services provider to purchase... See more »
May 28, 2021MarketScreener

Compensation policy for corporate officers, result of vote SM - 28 mai 2021.pdf

(marketscreener.com) COMPENSATION POLICY FOR CORPORATE OFFICERS COMBINED SHAREHOLDERS' MEETING OF 27 ... See more »
May 27, 2021FinanzNachrichten

Combined Shareholders' Meeting of Ipsen S.A. Held on 27 May 2021

All the Resolutions Submitted to the Shareholder's Vote Have Been Approved. Regulatory News: The Comb... See more »
May 19, 2021FiercePharma

Exelixis releases more details on Cabometyx thyroid cancer data that wooed Ipsen

ASCO: Exelixis releases more details on Cabometyx thyroid cancer data that wooed Ipsen nhigginsdunn W... See more »
May 17, 2021MarketScreener

Signes production site has received the Shingo (Gold) Award

(marketscreener.com) Ipsen's Signes production site has received the Shingo Award, the highest and mo... See more »
May 5, 2021FinanzNachrichten

Information Relating to the Combined Shareholders' Meeting of 27 May 2021

FORMALITIES FOR MAKING PREPARATORY DOCUMENTS AVAILABLE Regulatory News: Given the Covid-19 epidemic a... See more »

Ipsen Pharma Press Releases

March 2, 2021StreetInsider

Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen

Fusion to Leverage its Targeted Alpha Therapies (TAT) Expertise to Create FPI-2059, an Alpha-Emitting... See more »
February 25, 2021Business Wire

Ipsen, Pfizer Pharm and MSD Animal health topping the list of the Best Places To Work in Algeria 2021

ALGIERS, Algeria--(BUSINESS WIRE)-- #Algeria--Ipsen, Pfizer pharm and MSD Animal health are recognize... See more »
December 1, 2020Business Wire

Ipsen Highlights New Strategic Priorities and Provides Mid-Term Financial Outlook

PARIS--(BUSINESS WIRE)--Ipsen Highlights New Strategic Priorities and Provides Mid-Term Financial Out... See more »
October 12, 2020Korea Newswire

Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting

Galderma today announced the presentation of data from clinical trials of its aesthetic solutions and... See more »

Ipsen Pharma Videos

September 29, 2020Ipsen Pharma Youtube Channel

"Ipsen corporate" on YOUTUBE

September 9, 2020Ipsen Pharma Youtube Channel

"Listening Tour: Milton Park" on YOUTUBE

August 20, 2020Ipsen Pharma Youtube Channel

"Life With NET" on YOUTUBE

July 22, 2020Ipsen Pharma Youtube Channel

"7. Captured moments: Francois" on YOUTUBE

July 22, 2020Ipsen Pharma Youtube Channel

"Discover Ipsen Consumer HealthCare" on YOUTUBE

Social Media

Ipsen Pharma Headquarters

65 Quai Georges Gorse

Boulogne-Billancourt, Other92100

33-158-335-000

Driving Directions »

Trending Companies

Ipsen Pharma Summary

ABOUT

Overview

Ipsen is a pharmaceutical company that develops and commercializes generic medicines for the treatment of oncology and neuroscience diseases. Ipsen Pharma was founded in 1929. Ipsen Pharma's headquarters is located in Boulogne-Billancourt, Other, FR 9...

CEO

Ipsen Pharma's CEO, David Loew, currently has an approval rating of 86%. Ipsen Pharma's primary competitors are Mylan, TEVA & Regeneron.

Website

ipsen.com

Frequently Asked Questions about Ipsen Pharma

  1. When was Ipsen Pharma founded?

    Ipsen Pharma was founded in 1929
  2. Who is Ipsen Pharma's CEO?

    Ipsen Pharma's CEO is David Loew
  3. How much revenue does Ipsen Pharma generate?

    Ipsen Pharma generates $2.9B in revenue
  4. How much funding does Ipsen Pharma have?

    Ipsen Pharma has historically raised $0 in funding
  5. Where is Ipsen Pharma's headquarters?

    Ipsen Pharma's headquarters is in Boulogne-Billancourt Other, FR
  1. How many employees does Ipsen Pharma have?

    Ipsen Pharma has 5,800 employees
  2. What sector does Ipsen Pharma operate in?

    Ipsen Pharma is in Pharmaceuticals
  3. Who are Ipsen Pharma's competitors?

    Ipsen Pharma's top competitors are Mylan, TEVA, Regeneron
  4. Who has Ipsen Pharma invested in?

    Ipsen Pharma's has invested in companies such as Pyxis Oncology, Rhythm Pharmaceuticals, Inc., Dicerna